Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients

NCT02062983 is registered in ClinicalTrials.gov with National Guard Health Affairs as lead sponsor.

NCT NCT02062983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02062983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients
Lead sponsor
National Guard Health Affairs
Phase
Observational
Overall status
Suspended
Start date
June 30, 2012
Completion date
August 31, 2016
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer